1. Goetsch MF. Vulvar vestibulitis: prevalence and historic features in a general gynecologic practice population. Am J Obstet Gynecol. 1991;164(6 Pt 1):1609-1616.

2. White G, Jantos M. Sexual behavior changes with vulvar vestibulitis syndrome. J Reprod Med. 1998;43(9):783-789.

3. Foster D, Kotok M. Vulvodynia: psychological impact on the partner. NVA News. 2007;12(2):1-5.

4. Steege JF, et al., eds. Chronic Pelvic Pain: An Integrated Approach. New York, N.Y.: W. B. Saunders Company; 1998.

5. McKay M. Vulvitis and vulvovaginitis: cutaneous considerations. Am J Obstet Gynecol. 1991;165(4 Pt 2):1176-1182.

6. Bachmann G, et al. Vulvodynia: a state-of-the-art consensus on definitions, diagnosis and management. J Reprod Med. 2006;51(6):447-456.

7. Paavonen J. Diagnosis and treatment of vulvodynia. Ann Med. 1995;27:175-181.

8. Witkin SS, et al. Influence of interleukin-1 receptor antagonist gene polymorphism on disease. Clin Infect Dis. 2002;34(2):204-209.

9. Ekgren JS. Vulvovaginitis treated with anticholinergics. Gastroenterology International. 2000;13(2):72.

10. Westrom LV, Willen R. Vestibular nerve fiber proliferation in vulvar vestibulitis syndrome. Obstet Gynecol. 1998;91(4):572-576.

11. Zolnoun D, et al. A conceptual model for the pathophysiology of vulvar vestibulitis syndrome. Obstet Gynecol Surv. 2006;61(6):395-401.

12. Bornstein J, et al. Hyperinnervation and mast cell activation may be used as histopathologic diagnostic criteria for vulvar vestibulitis. Gynecol Obstet Invest. 2004;58(4):171?178.

13. Diatchenko L, et al. Genetic basis for individual variations in pain perception and the development of a chronic pain condition. Hum Mol Genet. 2005;14(1):135-143.

14. Scheinfeld N. The role of gabapentin in treating diseases with cutaneous manifestations and pain. Int J Dermatol. 2003;42(6):491-495.

15. Foster D, et al. Enhanced synthesis of proinflammatory cytokines by vulvar vestibulitis fibroblasts: implications for vulvar vestibulitis. Am J Obstet Gynecol. 2007;196(4):341e1-346e8.

16. Harlow BL, Stewart EG. A population-based assessment of chronic unexplained vulvar pain: have we underestimated the prevalence of vulvodynia? J Am Med Womens Assoc. 2003;58(2):82-88.

17. Bachmann GA, et al. Vulvodynia: a state-of-the-art consensus on definitions, diagnosis and management. J Reprod Med. 2006;51(6):447-456.

18. Lamont J, et al. Psychosexual profiles of women with vulvodynia. J Sex Marital Ther. 2001;27(5):551-555.

19. Danielsson I, et al. Vulvar vestibulitis: medical, psychosexual and psychosocial aspects. A case-control study. Acta Obstet Gynecol Scand. 2000;79(10):872-878.

20. Sadownik LA. Clinical profile of vulvodynia patients. A prospective study of 300 patients. J Reprod Med. 2000;45(8):679-684.

21. White G, et al. Establishing the diagnosis of vulvar vestibulitis. J Reprod Med. 1997;42(3):157-160.

22. Meana M, et al. Dyspareunia: sexual dysfunction or pain syndrome? J Nerv Ment Dis. 1997;185(9):561-589.

23. Reed BD, et al. Psychosocial and sexual functioning in women with vulvodynia and chronic pelvic pain. A comparative evaluation. J Reprod Med. 2000;45(8):624-632.

24. Arnold LD, et al. Vulvodynia: characteristics and associations with co-morbidities and quality of life. Obstet Gynecol. 2006;107(3):617-624.

25. Kellogg-Spadt S. Discussion, conclusions and recommendations. In: Listening to the Voices of Women Diagnosed with Vulvodynia. Philadelphia, Pa: ProQuest; 2002: 179-223.

26. Reed B, et al. Treatment of vulvodynia with tricyclic antidepressants: efficacy and associated factors. J Low Genit Tract Dis. 2006;10(4):245-251.

27. Harris G, et al. Evaluation of gabapentin in the treatment for generalized vulvodynia, unprovoked. J Reprod Med. 2007;52(2):103-106.

28. Nyirjesy P, et al. Cromolyn cream for recalcitrant idiopathic vulvar vestibulitis: results of a placebo controlled study. Sex Transm Infect. 2001;77(1)53-57.

29. Steinberg A, et al. Capsaicin for the treatment of vulvar vestibulitis. Am J Obstet Gynecol. 2005;192(5):1549-1553.

30. ter Kuile M, Weijenborg P. A cognitive-behavioral group program for women with vulvar vestibulitis syndrome: factors associated with treatment success. J Sex Marital Ther. 2006;32(3):199-213.

31. Reissing ED, et al. Vaginal spasm, pain and behavior: an empirical investigation of the diagnosis of vaginsmus. Arch Sex Behav. 2004;33(1):5-17.

32. Fisher K. Management of dyspareunia and associated levator ani muscle overactivity. Physical Therapy. 2007;87(7):935-941.

33. Herman H. Physical therapy for female sexual dysfunction. In: Women's Sexual Function and Dysfunction. Goldstein I, et al, eds. London, England: Taylor & Francis; 2005.

34. Manley G, Odom L. Treating female pelvic disorders using a combination of pelvic floor physical therapy and sex therapy. Contemp Sex. 2006;40(3):13-18.

35. Rosenbaum TY. Physiotherapy treatment of sexual pain disorders J Sex Marital Ther. 2005;31(4):329-340.

36. Fisher KA. Management of dyspareunia and associated levator ani muscle overactivity. Physical Therapy. 2007;87(7):935-941.

37. Oyama I, et al. Modified Thiele massage as therapeutic intervention for female patients with interstitial cystitis and high-tone pelvic floor dysfunction. Urology. 2004;64(5):862-865.

38. Wurn LJ, et al. Increasing orgasm and decreasing dyspareunia by a manual physical therapy technique. MedGenMed. 2004;6(4):47.

39. White G, et al. Establishing the diagnosis of vestibulitis. J Reprod Med. 1997;42(3):157-160.

40. Danielsson I, et al. EMG biofeedback versus topical lidocaine gel: a randomized study for the treatment of women with vulvar vestibulitis. Acta Obstet Gynecol Scand. 2006;85(11):1360-1370.

41. Fitzwater JB, et al. Electrical stimulation in the treatment of pelvic pain due to levator ani spasm. J Reprod Med. 2003;48(8):573-577.

42. Nappi RE, et al. Electrical stimulation in the management of sexual pain disorders. J Sex and Marital Therapy 2003;29(suppl 1):103-110.

44. Yoon H, et al. Botulinum toxin A for the management of vulvodynia. Int J Impot Res. 2007;19(1):84-87.

45. Schneider D, et al. Outcome of surgical treatment for superficial dyspareunia from vulvar vestibulitis. J Reprod Med. 2001;46(3):227-231.

46. Haefner H, et al. The Vulvodynia Guideline. NVA News. 2005;10(3):1-6.

47. Goldstein AT, et al. Surgical treatment of vulvar vestibulitis syndrome: outcome assessment derived from a post operative questionnaire. J Sex Med. 2006;3(5):923-931.